당기 순이익 변화 날짜
AbbVie USD 695M 1.12B 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amarin USD -1.22M 6.51M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
DBV Technologies USD -33.16M 8.71M 2025-09
Esperion Therapeutics USD 61.83M 93.16M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.16B 747M 2026-03